Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Helio Tedesco Silva Junior, Hospital do Rim e Hipertensão
ClinicalTrials.gov Identifier:
NCT01653041
First received: July 26, 2012
Last updated: August 15, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)